Nkọwa zuru ezu
Chlamydia pneumoniae (C. pneumoniae) bụ ụdị nje bacteria na-emekarị na ihe bụ isi na-akpata oyi baa gburugburu ụwa.Ihe dị ka 50% nke ndị toro eto nwere ihe akaebe nke ọrịa gara aga site na afọ 20, na ịmaliteghachi n'oge ndụ na-adịkarị.Ọtụtụ nchọpụta egosiwo njikọ kpọmkwem n'etiti ọrịa C. pneumoniae na ọrịa ndị ọzọ na-egbuke egbuke dị ka atherosclerosis, nnukwu exacerbations nke COPD, na ụkwara ume ọkụ.Nchọpụta nke ọrịa C. pneumoniae bụ ihe ịma aka n'ihi ọdịdị ngwa ngwa nke pathogen, nnukwu seroprevalence, na ohere nke ụgbọ ala asymptomatic na-agafe agafe.Ụzọ ụlọ nyocha achọpụtara nke ọma gụnyere ikewapụ akụkụ ahụ na omenala cell, nyocha serological na PCR.Nnwale Microimmunofluorescence (MIF), bụ “ọkọlọtọ ọla edo” dị ugbu a maka nyocha serological, mana nyocha ahụ ka enweghị nhazi yana ọ na-ama aka na teknụzụ.Immunoassay nke mgbochi bụ ule serology a na-ejikarị eme ihe yana ọrịa chlamydial bụ isi bụ nzaghachi IgM kachasị n'ime izu 2 ruo 4 yana nzaghachi IgG na IgA na-egbu oge n'ime izu 6 ruo 8.Agbanyeghị, na ị nwetaghachi, ọkwa IgG na IgA na-ebili ngwa ngwa, ọtụtụ mgbe n'ime izu 1-2 ebe ọkwa IgM nwere ike ọ dị ụkọ.N'ihi nke a, ọgwụ mgbochi IgA egosila na ọ bụ ihe nrịbama immunological nke a pụrụ ịdabere na ya nke isi, ọrịa na-adịghị ala ala na nke na-emekarị mgbe ọ na-ejikọta ya na nchọpụta nke IgM.